Table 1.
Demographic Information for PWLE and P/HCP Participants.
| PWLE (N = 17) | |
|---|---|
| Gender | |
| Women | 11 |
| Men | 6 |
| Age range | 21–77 years |
| Race a | |
| White | 12 |
| South Asian | 3 |
| Mixed | 2 |
| Had PGx testing? | |
| Yes | 7 |
| No | 10 |
| Health authority | |
| Vancouver Coastal | 6 |
| Fraser | 7 |
| Interior | 3 |
| Island | 1 |
| Northern | 0 |
| Education level | |
| High school | 2 |
| Attending university | 2 |
| Diploma/Associate degree | 4 |
| Bachelor’s degree | 7 |
| Graduate degree | 2 |
| P/HCP (N = 15) b | |
| Gender | |
| Women | 9 |
| Men | 6 |
| Race | |
| White | 10 |
| Southeast Asian | 2 |
| East Asian | 1 |
| Middle Eastern | 1 |
| Mixed | 1 |
| Professional role | |
| Clinical c | 9 |
| Psychiatrist | 3 |
| Pharmacist | 2 |
| Family Physician | 2 |
| Genetic Counsellor | 1 |
| Nurse | 1 |
| Lab (public and private) | 2 |
| Policy/Leadership | 2 |
| Private Insurance | 2 |
Note. PGx = pharmacogenomics; PWLE = people with lived experience; P/HCP = healthcare providers and policy experts.
Participants were asked about their ethnic background; data are presented as race categories to match how participants self-described.
The interviewer EM had previously met several of the P/HCP participants but did not know them well (with one exception). This degree of familiarity could have influenced the interviews, but we suggest that this influence would be positive, in that the acquaintance might have allowed more candid conversation.
7 out of 9 participants in clinical roles had experience with discussing PGx testing with patients in some capacity; 2/9 had no experience discussing PGx testing.